Keywords: nolvadex, ok, male, breast, cancer, zeneca, pharmaceutical

NOLVADEX US OK FOR MALE BREAST CANCER

Article | 26 July 1993

Print This

Zeneca, the pharmaceutical split-off of the ICI group, has announced that the anticancer agent Nolvadex (tamoxifen) has been approved for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in